Exelixis, Inc.EXEL
NasdaqGS•Healthcare•Biotechnology
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $2.38B, growing 3.3% year-over-year. TTM net income stood at $833.42M (29.5% growth). Quarterly EBITDA was $258.29M and operating income was $251.34M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze EXEL growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters